0001213900-19-001621.txt : 20190204 0001213900-19-001621.hdr.sgml : 20190204 20190204092905 ACCESSION NUMBER: 0001213900-19-001621 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190204 DATE AS OF CHANGE: 20190204 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-58217 FILM NUMBER: 19561837 BUSINESS ADDRESS: STREET 1: 5 WEST FORSYTH STREET STREET 2: SUITE 200 CITY: JACKSONVILLE STATE: FL ZIP: 32202 BUSINESS PHONE: (904) 516-5436 MAIL ADDRESS: STREET 1: 5 WEST FORSYTH STREET STREET 2: SUITE 200 CITY: JACKSONVILLE STATE: FL ZIP: 32202 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Brio Capital Master Fund Ltd. CENTRAL INDEX KEY: 0001560894 IRS NUMBER: 981072321 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O BRIO CAPITAL MANAGEMENT LLC STREET 2: 100 MERRICK ROAD SUITE 401W CITY: ROCKVILLE CENTRE STATE: NY ZIP: 11570 BUSINESS PHONE: 516-536-0500 MAIL ADDRESS: STREET 1: C/O BRIO CAPITAL MANAGEMENT LLC STREET 2: 100 MERRICK ROAD SUITE 401W CITY: ROCKVILLE CENTRE STATE: NY ZIP: 11570 SC 13G/A 1 sc13g0119a4brio_markertherap.htm AMENDMENT NO. 4 TO SCHEDULE 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(AMENDMENT NO. 4)

 

MARKER THERAPEUTICS, INC.
(Name of Issuer)
 
COMMON STOCK, PAR VALUE $0.001
(Title of Class of Securities)
 
876033309
(CUSIP Number)
 
December 31, 2018
(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

   Rule 13d-1(b)

   Rule 13d-1(c)

   Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No.   876033309

 

1.  

Names of Reporting Persons

 

Brio Capital Master Fund Ltd.

 

2.  

Check the Appropriate Box if a Member of a Group  (See Instructions)

(a)  ☐

(b)  ☐

 

3.  

SEC Use Only

 

 

4.  

Citizenship or Place of Organization

 

Cayman Islands 

 

Number of
Shares

Beneficially Owned

By Each Reporting

Person With:

5.

Sole Voting Power

 

237,496 shares of common stock(1)

 

6.

Shared Voting Power

 

0

 

7.

Sole Dispositive Power

 

237,496 shares of common stock(1)

 

8.

Shared Dispositive Power

 

0

 

9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

237,496 shares of common stock(1)

 

10.  

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares ☒

See footnote (1) below.

 

11.  

Percent of Class Represented by Amount in Row (9)

 

0.05%

 

12.  

Type of Reporting Person (See Instructions)

 

CO

 

 

(1) Brio Capital Management LLC, is the investment manager of Brio Capital Master Fund Ltd. and has the voting and investment discretion over securities held by the Brio Capital Fund Ltd. Shaye Hirsch, in his capacity as Managing Member of Brio Capital Management LLC, makes voting and investment decisions on behalf of Brio Capital Management LLC in its capacity as the investment manager of Brio Capital Master Fund Ltd.

 

 2 

 

 

Item 1(a). Name of Issuer
   
  Marker Therapeutics, Inc.
   
Item 1(b). Address of the Issuer’s Principal Executive Offices
   
  5 West Forsyth Street, Suite 200, Jacksonville, FL  32202
   
Item 2(a). Names of Person Filing
   
  Brio Capital Master Fund Ltd.

 

Item 2(b). Address of the Principal Business Office, or if none, Residence:
   
  c/o Brio Capital Management LLC, 100 Merrick Road, Suite 401 W. Rockville Center, NY 11570.
   
Item 2(c). Citizenship
   
  Cayman Islands

 

Item 2(d). Title of Class of Securities
   
  Common Stock, $0.001 par value per share.
   
Item 2(e). CUSIP Number
   
  876033309
   
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

  

  ¨ (a)  Broker or Dealer registered under Section 15 of the Exchange Act.
     
  ¨ (b) Bank as defined in Section 3(a)(b) or the Exchange Act.
     
  ¨ (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.
     
  ¨ (d) Investment company registered under Section 8 of the Investment Company Act.

 

  ¨ (e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).
     
  ¨ (f)  An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).
     
  ¨ (g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).
     
  ¨ (h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.
     
  ¨

(i) A Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

     
  ¨ (j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).
     
    Not applicable

 

 3 

 

 

Item 4.

 

Ownership

 

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the Cover Page and is incorporated herein by reference.

 

Item 5. Ownership of Five Percent or Less of a Class
   
  Reporting Person owns less than 5%.
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person
   
  Not Applicable 
   
Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported On By the Parent Holding Company

   
  Not Applicable
   
Item 8. Identification and Classification of Members of the Group
   
  Not Applicable
   
Item 9. Notice of Dissolution of Group
   
  Not Applicable
   
Item 10. Certification
   
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

                           
 4 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

DATE:   February 4, 2019

  

 

Brio Capital Master Fund Ltd.,

a Cayman Islands Exempted Company

   
  By: Brio Capital Management LLC, its Investment Manager
   
  By: /s/ Shaye Hirsch
    Name: Shaye Hirsch
    Title: Managing Member

 

Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations

(See 18 U.S.C. 1001)

 

 5